Markov-Modeling for the Administration of Platinum Analogues and Paclitaxel as First-Line Chemotherapy as Well as Topotecan and Liposomal Doxorubicin as Second-Line Chemotherapy With Epithelial Ovarian Carcinoma

Journal of Cancer Research and Clinical Oncology - Germany

doi 10.1007/s00432-007-0313-y